Literature DB >> 18794346

Tuberous sclerosis complex proteins control axon formation.

Yong-Jin Choi1, Alessia Di Nardo, Ioannis Kramvis, Lynsey Meikle, David J Kwiatkowski, Mustafa Sahin, Xi He.   

Abstract

Axon formation is fundamental for brain development and function. TSC1 and TSC2 are two genes, mutations in which cause tuberous sclerosis complex (TSC), a disease characterized by tumor predisposition and neurological abnormalities including epilepsy, mental retardation, and autism. Here we show that Tsc1 and Tsc2 have critical functions in mammalian axon formation and growth. Overexpression of Tsc1/Tsc2 suppresses axon formation, whereas a lack of Tsc1 or Tsc2 function induces ectopic axons in vitro and in the mouse brain. Tsc2 is phosphorylated and inhibited in the axon but not dendrites. Inactivation of Tsc1/Tsc2 promotes axonal growth, at least in part, via up-regulation of neuronal polarity SAD kinase, which is also elevated in cortical tubers of a TSC patient. Our results reveal key roles of TSC1/TSC2 in neuronal polarity, suggest a common pathway regulating polarization/growth in neurons and cell size in other tissues, and have implications for the understanding of the pathogenesis of TSC and associated neurological disorders and for axonal regeneration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18794346      PMCID: PMC2546692          DOI: 10.1101/gad.1685008

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  46 in total

1.  Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3beta and its upstream regulators.

Authors:  Hui Jiang; Wei Guo; Xinhua Liang; Yi Rao
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

2.  The establishment of polarity by hippocampal neurons in culture.

Authors:  C G Dotti; C A Sullivan; G A Banker
Journal:  J Neurosci       Date:  1988-04       Impact factor: 6.167

Review 3.  Neuronal polarity.

Authors:  A M Craig; G Banker
Journal:  Annu Rev Neurosci       Date:  1994       Impact factor: 12.449

4.  Identification and characterization of a novel (115 kDa) neurofilament-associated kinase.

Authors:  J Xiao; M J Monteiro
Journal:  J Neurosci       Date:  1994-03       Impact factor: 6.167

5.  Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain.

Authors:  Y Zhu; M I Romero; P Ghosh; Z Ye; P Charnay; E J Rushing; J D Marth; L F Parada
Journal:  Genes Dev       Date:  2001-04-01       Impact factor: 11.361

6.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.

Authors:  Ken Inoki; Yong Li; Tianquan Zhu; Jun Wu; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

7.  Akt regulates growth by directly phosphorylating Tsc2.

Authors:  Christopher J Potter; Laura G Pedraza; Tian Xu
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

8.  The TSC1 tumor suppressor hamartin interacts with neurofilament-L and possibly functions as a novel integrator of the neuronal cytoskeleton.

Authors:  Luciana A Haddad; Nicole Smith; Mark Bowser; Yo Niida; Vanishree Murthy; Charo Gonzalez-Agosti; Vijaya Ramesh
Journal:  J Biol Chem       Date:  2002-09-10       Impact factor: 5.157

9.  Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.

Authors:  Andrew R Tee; Diane C Fingar; Brendan D Manning; David J Kwiatkowski; Lewis C Cantley; John Blenis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

10.  Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway.

Authors:  Brendan D Manning; Andrew R Tee; M Nicole Logsdon; John Blenis; Lewis C Cantley
Journal:  Mol Cell       Date:  2002-07       Impact factor: 17.970

View more
  138 in total

1.  Synapses of amphids defective (SAD-A) kinase promotes glucose-stimulated insulin secretion through activation of p21-activated kinase (PAK1) in pancreatic β-Cells.

Authors:  Jia Nie; Chao Sun; Omar Faruque; Guangming Ye; Jia Li; Qiangrong Liang; Zhijie Chang; Wannian Yang; Xiao Han; Yuguang Shi
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  Loss of white matter microstructural integrity is associated with adverse neurological outcome in tuberous sclerosis complex.

Authors:  Jurriaan M Peters; Mustafa Sahin; Vanessa K Vogel-Farley; Shafali S Jeste; Charles A Nelson; Matthew C Gregas; Sanjay P Prabhu; Benoit Scherrer; Simon K Warfield
Journal:  Acad Radiol       Date:  2012-01       Impact factor: 3.173

3.  RHEB/mTOR hyperactivity causes cortical malformations and epileptic seizures through increased axonal connectivity.

Authors:  Martina Proietti Onori; Linda M C Koene; Carmen B Schäfer; Mark Nellist; Marcel de Brito van Velze; Zhenyu Gao; Ype Elgersma; Geeske M van Woerden
Journal:  PLoS Biol       Date:  2021-05-26       Impact factor: 8.029

Review 4.  Initiating and growing an axon.

Authors:  F Polleux; William Snider
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04       Impact factor: 10.005

Review 5.  GSK3 signalling in neural development.

Authors:  Eun-Mi Hur; Feng-Quan Zhou
Journal:  Nat Rev Neurosci       Date:  2010-08       Impact factor: 34.870

6.  Activating the translational repressor 4E-BP or reducing S6K-GSK3β activity prevents accelerated axon growth induced by hyperactive mTOR in vivo.

Authors:  Xuan Gong; Longbo Zhang; Tianxiang Huang; Tiffany V Lin; Laura Miyares; John Wen; Lawrence Hsieh; Angélique Bordey
Journal:  Hum Mol Genet       Date:  2015-07-28       Impact factor: 6.150

7.  Neuronal development: SAD kinases make happy axons.

Authors:  Lei Xing; Jason M Newbern; William D Snider
Journal:  Curr Biol       Date:  2013-09-09       Impact factor: 10.834

8.  The Rheb-mTOR pathway is upregulated in reactive astrocytes of the injured spinal cord.

Authors:  Simone Codeluppi; Camilla I Svensson; Michael P Hefferan; Fatima Valencia; Morgan D Silldorff; Masakatsu Oshiro; Martin Marsala; Elena B Pasquale
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

9.  Reduction in retinal nerve fiber layer thickness in tuberous sclerosis complex.

Authors:  Leonardo Emberti Gialloreti; Romina Moavero; Sara Marciano; Matteo Pardini; Francesca Benassi; Maria Giulia Mutolo; Paolo Curatolo
Journal:  Childs Nerv Syst       Date:  2015-04-25       Impact factor: 1.475

Review 10.  Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment.

Authors:  Ken Inoki; Kun-Liang Guan
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.